UNSPSC 51201820: Thymopentin

This classification denotes an immunostimulant with the molecular formula C30H49N9O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O3Y80ZF13F, chemically known as l-tyrosine, n-(n-(n-(n(sup 2)-l-arginyl-l-lysyl)-l-alpha-aspartyl)-l-valyl)- but generally known as thymopentin, which bears US NIH Compound Identifier 50587. European Medicines Agency schedules Thymopentin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10993MIG.

UNSPSC 51201820 Thymopentin is a Commodity code under which state and local health departments procure pharmaceutical products; however, the single recent opportunity posted under this code — a Mississippi State Department of Health sole source notice for Yellow Fever Vaccine from Sanofi Pasteur — appears unrelated to thymopentin, an immune-modulating pharmaceutical distinct from viral vaccines. The source data show no current state or local solicitations for thymopentin itself, and the Yellow Fever Vaccine notice does not reflect typical activity for this code.

Without additional recent opportunities tagged to this Commodity code, geographic spread and representative procurement patterns cannot be characterized from available data. The Mississippi notice is a sole source objection period (due August 3, 2026) rather than an open competitive vehicle; it does not indicate the volume, term, or estimated value of the purchase. Firms evaluating this code should verify whether state and local procurement systems are correctly classifying thymopentin acquisitions or whether health department vaccine and pharmaceutical purchases are concentrated under different UNSPSC codes.